Clover Health Files 8-K for Officer/Director Changes
Ticker: CLOV · Form: 8-K · Filed: Apr 1, 2026 · CIK: 0001801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2026 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, legal-filing
Related Tickers: CLOV
TL;DR
CLOV filed an 8-K on 3/30/26 for officer/director changes and other events.
AI Summary
Clover Health Investments, Corp. filed an 8-K on April 1, 2026, reporting events related to Item 5.02 (Departure/Election of Officers/Directors) and Item 8.01 (Other Events). The filing date indicates a report submitted on March 30, 2026.
Why It Matters
This filing signals potential shifts in Clover Health's leadership or significant corporate events that could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: medium — Filings related to officer and director changes can indicate internal instability or strategic shifts, warranting closer examination.
Key Numbers
- 0001801170-26-000080 — SEC Accession Number (Unique identifier for this specific filing)
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Filer of the 8-K
- 0001801170 (company) — CIK number for Clover Health Investments, Corp.
- 2026-04-01 (date) — Filing Date of the 8-K
- 2026-03-30 (date) — Period of Report for the 8-K
FAQ
What specific changes occurred regarding directors or officers on March 30, 2026?
The filing indicates Item 5.02 covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers,' but the specific details of these changes are not provided in the summary information.
What 'Other Events' are reported under Item 8.01?
The provided filing details do not specify the nature of the 'Other Events' reported under Item 8.01.
When was this 8-K filing officially accepted by the SEC?
The filing was accepted on 2026-04-01 at 08:32:45.
What is the CIK number for Clover Health Investments, Corp.?
The CIK number for Clover Health Investments, Corp. is 0001801170.
What is the primary business classification for Clover Health Investments, Corp. according to the SIC code?
The SIC code listed is 6324, which corresponds to Hospital & Medical Service Plans.
Filing Stats: 1,309 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2026-04-01 08:32:45
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20260330.htm (8-K) — 34KB
- exhibit991.htm (EX-99.1) — 11KB
- exhibit991001.jpg (GRAPHIC) — 227KB
- exhibit991002.jpg (GRAPHIC) — 292KB
- exhibit991003.jpg (GRAPHIC) — 128KB
- 0001801170-26-000080.txt ( ) — 1048KB
- clov-20260330.xsd (EX-101.SCH) — 2KB
- clov-20260330_lab.xml (EX-101.LAB) — 22KB
- clov-20260330_pre.xml (EX-101.PRE) — 13KB
- clov-20260330_htm.xml (XML) — 2KB
01. Other Events
Item 8.01. Other Events. On April 1, 2026, the Company issued a press release announcing Mr. Kuipers' departure from the Company and Mr. Thornton's appointment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press Release of the Company, dated April 1, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: April 1, 2026 By: /s/ Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary